Syncona
Venture capital
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
6Deep-tech portfolio3 active
3Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Purespring Therapeutics
1Co-investorsShare a portfolio company
Portfolio · 6 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Beacon Therapeutics | Biotech | Active | — | — |
| Purespring Therapeutics | Biotech | Active | — | — |
| Quell Therapeutics | Biotech | Active | — | — |
| Autolus Therapeutics | Biotech | Public | — | — |
| Resolution Bioscience | Medtech | Acquired | — | — |
| SwanBio Therapeutics | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#67
Portfolio exits#69
Raises, 12 months#88
Co-investors#243
Co-investors
- SV Health InvestorsVenture capital1 shared
Sectors
- Biotech5
- Medtech1
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.